HDAC8 Prevents Anthrax Lethal Toxin-induced Cell Cycle Arrest through Silencing PTEN in Human Monocytic THP-1 Cells

Toxins
Soon-Duck HaSung Ouk Kim

Abstract

Anthrax lethal toxin (LeTx) is a cytotoxic virulence factor that causes cell cycle arrest and cell death in various cell types. However, susceptibility to the cytotoxic effects varies depending on cell types. In proliferating monocytes, LeTx has only transient cytotoxic effects due to activation of the phosphoinositide 3-kinase (PI3K)-AKT-mediated adaptive responses. To date, the mechanism of LeTx in activating PI3K-AKT signaling axis is unknown. This study shows that the histone deacetylase 8 (HDAC8) is involved in activating PI3K-AKT signaling axis through down-regulating the phosphatase and tensin homolog 1 (PTEN) in human monocytic THP-1 cells. The HDAC8-specific activator TM-2-51 and inhibitor PCI-34051 enhanced and prevented, respectively, AKT activation and cell cycle progression in LeTx-treated cells. Furthermore, HDAC8 induced tri-methylation of histone H3 lysine 27 (H3K27me3), which is known to suppress PTEN expression, through at least in part down-regulating the H3K27me3 eraser Jumonji Domain Containing (JMJD) 3. Importantly, the JMJD3-specific inhibitor GSK-J4 induced AKT activation and protected cell cycle arrest in LeTx-treated cells, regardless the presence of HDAC8 activity. Collectively, this study for the fir...Continue Reading

References

Sep 8, 2001·Molecular Cell·V StambolicT W Mak
Dec 12, 2001·Molecular Microbiology·C Guidi-RontaniM Mock
Feb 28, 2002·Proceedings of the National Academy of Sciences of the United States of America·Han-Mo KooGeorge F Vande Woude
Jun 11, 2002·Biochemical and Biophysical Research Communications·Serguei G PopovKen Alibek
Jan 2, 2003·Molecular and Cellular Biology·Kristie L DurstScott W Hiebert
Feb 5, 2003·Nature Structural Biology·Gianluca CanettieriMarc Montminy
Oct 1, 2003·The Journal of Biological Chemistry·Roger A MooreheadRama Khokha
Oct 2, 2003·Proceedings of the National Academy of Sciences of the United States of America·Isabelle I SallesJimmy D Ballard
Dec 23, 2003·Infection and Immunity·James E Kirby
Feb 9, 2005·The Journal of Experimental Medicine·Silvia Rossi PaccaniCosima T Baldari
Mar 18, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·David WaltregnyVincent Castronovo
Nov 22, 2005·Infection and Immunity·Jason E ComerRolf König
Jan 24, 2006·Nature Genetics·Eric D Boyden, William F Dietrich
May 4, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Hui FangDavid M Frucht
Jan 17, 2007·Cellular Microbiology·Jean-Nicolas TournierDominique R Vidal
Jul 12, 2007·The Journal of Biological Chemistry·Soon-Duck HaSung Ouk Kim
Mar 7, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Lixin XuDavid M Frucht
Oct 9, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Wenxin WuJordan P Metcalf
May 21, 2010·Molecular Endocrinology·Brian J WilsonVincent Giguère
Jun 7, 2011·Journal of Chemical Biology·Lok Hang MakRudiger Woscholski
Jun 15, 2011·Oncotarget·Jonathan R Hart, Peter K Vogt
Aug 2, 2011·The Journal of Biological Chemistry·Magdalena Karolczak-BayattiG Nicholas Europe-Finner
Feb 7, 2012·Journal of Cellular Physiology·Kiran Mahajan, Nupam P Mahajan
Mar 13, 2012·Cell Metabolism·Ana Ortega-MolinaManuel Serrano

❮ Previous
Next ❯

Datasets Mentioned

BETA
LY294002

Methods Mentioned

BETA
acetylation
PCR
FACS

Software Mentioned

ModFit LT
Cell Quest
GraphPad Prism
GraphPad

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.